Home » Topics » BioWorld Science

BioWorld Science
RSS

Serum indoxyl sulfate as independent biomarker of arterial stiffness in CAD

April 3, 2020

Novel bleomycin-induced cynomolgus monkey model of IPF

April 3, 2020

Leronlimab shows potential immunological restoration in severely ill COVID-19 patients

April 3, 2020

Update on phase II study of ifenprodil in patients with COVID-19

April 3, 2020

Topline phase Ib/IIa results for AB-2004 in patients with ASD

April 3, 2020

Positive data from investigator-initiated trial of DAS-181 for the treatment of COVID-19

April 3, 2020

First patient dosed in phase I/IIa study of TJC-4 in China

April 3, 2020

Females, males have different metabolic response to intermittent fasting

April 3, 2020

Arena reports topline phase I data on controlled-release etrasimod

April 2, 2020

Interim analysis from study of siltuximab in patients with COVID-19 and respiratory complications

April 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...